Conafay Group Federal funding landscape updates

As we approach the end of FY26 and the FY27 appropriations cycle continues to unfold, join The Conafay Group for a mid-year analysis of the federal funding landscape as it relates to health, defense health, and biosecurity. This session brings together Conafay Group subject-matter experts with direct funding agency and Capitol Hill experience, each offering their read on where things stand. Topics will include the status of FY27 appropriations, the defense authorization, and aligned near-term priorities at BARDA for national health security. The panel will close with a short, moderated discussion connecting these three vantage points, followed by open Q&A. Attendees will leave with a clear, current picture of the funding landscape they can apply directly to their own federal engagement planning. The Conafay Group (TCG) is a Washington, DC-based federal government relations and consulting firm that specializes in non-dilutive funding and health policy advocacy for biopharma, medical device, academic, and research clients. Its service mix spans federal government relations, non-dilutive funding strategy, coalition and ally development, public-private partnerships, and B2B partnering, with notable depth in defense health channels.